| |
| |
|
| Insider
Information: |
Parini Michael |
| Relationship: |
EVP, Chief Adm, Leg & ... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,895,504 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,837 |
|
|
| Total
Value |
$14,895,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Adm, Leg & ... |
2021-02-25 |
30,837 |
2016-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-26 |
4 |
AS |
$159.56 |
$6,103,170 |
D/D |
(38,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-26 |
4 |
OE |
$122.45 |
$4,683,713 |
D/D |
38,250 |
77,859 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
36,693 |
68,246 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,389 |
57,227 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,641 |
52,134 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,204 |
28,554 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-11 |
4 |
AS |
$243.42 |
$4,154,832 |
D/D |
(16,882) |
37,906 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,604 |
52,763 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CLO |
• – – |
2016-01-04 |
4 |
A |
$0.01 |
$138 |
D/D |
13,800 |
13,800 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-10 |
4 |
D |
$240.95 |
$3,242,705 |
D/D |
(13,458) |
54,788 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-12 |
4 |
AS |
$153.41 |
$1,861,784 |
D/D |
(12,136) |
39,998 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-11 |
4 |
AS |
$179.48 |
$2,187,190 |
D/D |
(12,136) |
40,627 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-07-19 |
4 |
OE |
$86.52 |
$968,970 |
D/D |
10,829 |
39,638 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$1,743,469 |
D/D |
(10,829) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-18 |
4 |
AS |
$210.08 |
$1,657,556 |
D/D |
(7,825) |
36,281 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-04-16 |
4 |
AS |
$179.84 |
$1,160,166 |
D/D |
(6,375) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-04-16 |
4 |
OE |
$90.29 |
$712,279 |
D/D |
6,375 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-17 |
4 |
D |
$211.75 |
$1,321,320 |
D/D |
(6,240) |
44,106 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-02-19 |
4 |
AS |
$186.79 |
$1,051,585 |
D/D |
(5,624) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2020-02-03 |
4 |
AS |
$229.07 |
$1,025,350 |
D/D |
(4,436) |
31,553 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2021-02-11 |
4 |
AS |
$210.43 |
$909,179 |
D/D |
(4,318) |
50,346 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-05 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
43,859 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-05 |
4 |
AS |
$168.38 |
$715,615 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-04 |
4 |
AS |
$191.58 |
$814,215 |
D/D |
(4,250) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-04 |
4 |
OE |
$122.45 |
$520,413 |
D/D |
4,250 |
43,859 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
